The novel potent and selective PDE IV inhibitors

被引:0
|
作者
Ukita, T [1 ]
Sugahara, M [1 ]
Terakawa, Y [1 ]
Kikkawa, H [1 ]
Wada, K [1 ]
机构
[1] TANABE SEIYAKU CO LTD,LEAD OPTIMIZAT RES LAB,YODOGAWA KU,OSAKA 532,JAPAN
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:91 / MEDI
页数:1
相关论文
共 50 条
  • [31] Synthetic studies on selective type IV phosphodiesterase(PDE IV) inhibitors. III.
    Iwata, M
    Takayama, K
    Hisamichi, H
    Kubota, H
    Kawano, N
    Aoki, M
    Isomura, Y
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U215 - U215
  • [32] Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitors
    Lacombe, P
    Deschênes, D
    Dubé, D
    Dubé, L
    Gallant, M
    Macdonald, D
    Mastracchlo, A
    Perrier, H
    Charleson, S
    Huang, Z
    Laliberté, F
    Liu, S
    Mancini, JA
    Masson, P
    Salem, M
    Styhler, A
    Girard, Y
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (10) : 2608 - 2612
  • [33] Novel, potent and selective angiotensin IV short analogues
    Lukaszuk, Aneta
    Demaegdt, Heidi
    Karoyan, Philippe
    Vanderheyden, Patrick
    Vauquelin, Georges
    Tourwe, Dirk
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 143 - 144
  • [34] First Optimization of Novel, Potent, Selective PDE11A4 Inhibitors for Age-Related Cognitive Decline
    Mahmood, Shams ul
    Lozano Gonzalez, Mariana
    Tummalapalli, Sreedhar
    Eberhard, Jeremy
    Ly, Judy
    Hoffman, Charles
    Kelly, Michy
    Gordon, John
    Colussi, Dennis
    Childers, Wayne
    Rotella, David
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (21) : 14597 - 14608
  • [35] A novel series of potent and selective PDE5 inhibitors with potential for high and dose-independent oral bioavailability
    Allerton, Charlotte M. N.
    Barber, Christopher G.
    Beaumont, Kevin C.
    Brown, David G.
    Cole, Susan M.
    Ellis, David
    Lane, Charlotte A. L.
    Maw, Graham N.
    Mount, Natalie M.
    Rawson, David J.
    Robinson, Colin M.
    Street, Stephen D. A.
    Summerhill, Nicholas W.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) : 3581 - 3594
  • [36] Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitors
    Tsai, Ting-Yueh
    Hsu, Tsu
    Chen, Chiung-Tong
    Cheng, Jai-Hong
    Yeh, Teng-Kuang
    Chen, Xin
    Huang, Chung-Yu
    Chang, Chung-Nien
    Yeh, Kai-Chia
    Hsieh, Su-Huei
    Chien, Chia-Hui
    Chang, Yi-Wei
    Huang, Chih-Hsiang
    Huang, Yu-Wen
    Huang, Chen-Lung
    Wu, Ssu-Hui
    Wang, Min-Hsien
    Lu, Cheng-Tai
    Chao, Yu-Sheng
    Jiaang, Weir-Torn
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (06) : 2388 - 2399
  • [37] Potent and selective azetidine-based dipeptidyl peptidase IV (DPP IV) inhibitors
    Li, WX
    Oliver, E
    Rojas, C
    Lauter, S
    Thomas, B
    Belyakov, S
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U145 - U146
  • [38] Pyrimidinylpyrroloquinolones as highly potent and selective PDE5 inhibitors for treatment of erectile dysfunction
    Sui, ZH
    Guan, JH
    Macielag, MJ
    Jiang, WQ
    Zhang, SY
    Qiu, YH
    Kraft, P
    Bhattacharjee, S
    John, TM
    Haynes-Johnson, D
    Clancy, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (19) : 4094 - 4096
  • [39] Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, Part I: Transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitors
    Plummer, Mark S.
    Cornicelli, Joseph
    Roark, Howard
    Skalitzky, Donald J.
    Stankovic, Charles J.
    Bove, Susan
    Pandit, Jayvardhan
    Goodman, Annise
    Hicks, James
    Shahripour, Aurash
    Beidler, David
    Lu, Xiao Kang
    Sanchez, Brian
    Whitehead, Christopher
    Sarver, Ron
    Braden, Timothy
    Gowan, Richard
    Shen, Xi Qiang
    Welch, Katherine
    Ogden, Adam
    Sadagopan, Nalini
    Baum, Heidi
    Miller, Howard
    Banotai, Craig
    Spessard, Cindy
    Lightle, Sandra
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (11) : 3438 - 3442
  • [40] Heteroatom-bridged substituted 8-arylquinolines as potent PDE IV inhibitors.
    Lacombe, P
    Deschênes, D
    Dubé, D
    Dubé, L
    Gallant, M
    Macdonald, D
    Mastracchio, A
    Perrier, H
    Charleson, S
    Huang, Z
    Laliberté, F
    Mancini, JA
    Masson, P
    Styhler, A
    Nicholson, DW
    Girard, Y
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U64 - U64